牛牛AI助理已提取核心訊息
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb (BMY), was involved in a transaction with the company's stock on February 1, 2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a result, the total value of the shares after the action remains unknown.
Phyllis R. Yale, a reporting person for Bristol-Myers Squibb (BMY), was involved in a transaction with the company's stock on February 1, 2024. The specific details of the transaction, such as the action type, status, number of shares, nature of shares, transaction price, and post-transaction holdings, were not disclosed in the announcement. As a result, the total value of the shares after the action remains unknown.
百時美施貴寶（BMY）的舉報人菲利斯·耶魯於2024年2月1日參與了該公司股票的交易。公告中未披露交易的具體細節，例如行動類型、狀態、股票數量、股票性質、交易價格和交易後持有量。因此，行動後股票的總價值仍然未知。
百時美施貴寶（BMY）的舉報人菲利斯·耶魯於2024年2月1日參與了該公司股票的交易。公告中未披露交易的具體細節，例如行動類型、狀態、股票數量、股票性質、交易價格和交易後持有量。因此，行動後股票的總價值仍然未知。
有用
沒用